Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/79564
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome |
Author: | Hodge, G. Hodge, S. Ahern, J. Liew, C. Reynolds, P. Holmes, M. |
Citation: | Clinical and Experimental Immunology, 2013; 173(1):150-160 |
Publisher: | Blackwell Publishing Ltd |
Issue Date: | 2013 |
ISSN: | 0009-9104 1365-2249 |
Statement of Responsibility: | G. Hodge, S. Hodge, J. Ahern, C.-L. Holmes-Liew, P. N. Reynolds and M. Holmes |
Abstract: | Bronchiolitis obliterans syndrome (BOS) is associated with lack of immunosuppression of T cell proinflammatory cytokines and increased T cell granzyme B. Repeated antigen-driven proliferation down-regulates T cell CD28. We hypothesized that down-regulation of CD28 and up-regulation of alternate co-stimulatory molecules (CD134, CD137, CD152 and CD154) on T cells may be associated with BOS. Co-stimulatory molecules, granzyme B, perforin and intracellular cytokines were measured by flow cytometry on T cells from stable lung transplant patients (n = 38), patients with BOS (n = 20) and healthy controls (n = 10). There was a significant increase in the percentage of CD4/28null and CD8/28null T cells producing granzyme B, interferon (IFN)-γ and tumour necrosis factor (TNF)-α in BOS compared with stable patients. Down-regulation of CD28 was associated with steroid resistance and up-regulation of CD134, CD137, CD152 and CD154 on CD4+ T cells and CD137 and CD152 on CD8+ T cells. There was a significant correlation between increased CD28null/CD137 T cells producing IFN-γ, TNF-α with BOS grade (r = 0•861, P < 0•001 for CD28null/CD137 IFN-γ/CD8) and time post-transplant (r = 0•698, P < 0•001 for CD28null/CD137 IFN-γ/CD8). BOS is associated with down-regulation of CD28 and up-regulation of alternate co-stimulatory molecules on steroid-resistant peripheral blood proinflammatory CD4+ and CD8+ T cells. Therapeutic targeting of alternate co-stimulatory molecules on peripheral blood CD28null T cells and monitoring response using these assays may help in the management of patients with BOS. |
Keywords: | BOS CD28null lung transplant proinflammatory T cells |
Rights: | © 2013 British Society for Immunology |
DOI: | 10.1111/cei.12081 |
Grant ID: | NHMRC |
Published version: | http://dx.doi.org/10.1111/cei.12081 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.